BEN-MAIMON CAROLE - Insider Non-Derivative Transactions at Larimar Therapeutics, Inc. (LRMR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 17, 2024, BEN-MAIMON CAROLE's relationship to Larimar Therapeutics, Inc. (LRMR) is Director,Officer (President and CEO), and currently has 332,954 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LRMR insiders.
Data Source: SEC.
BEN-MAIMON CAROLE - Insider Non-Derivative Transactions of LRMR Common Stock
BEN-MAIMON CAROLE - Insider Non-Derivative Transactions at LRMR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 18, 2024 | Acquisition -- (Common Stock) | 66125 | 0 | 332954 |
| May 18, 2023 | P -- (Common Stock) | 5000 | 3.71 | 266829 |
| Feb 1, 2023 | Acquisition -- (Common Stock) | 205000 | 0 | 261829 |